How often is Nexviazyme given? Understanding the Treatment Schedule
•
2 min read
Nexviazyme (avalglucosidase alfa-ngpt) is a specific enzyme replacement therapy approved for late-onset Pompe disease (LOPD) in patients one year of age and older. The standard recommendation is to administer this medication as an intravenous (IV) infusion every two weeks. This consistent administration schedule is a fundamental aspect of managing this rare genetic condition by providing a steady supply of the missing enzyme.
